|
Legacy Pharmaceuticals International is a customer-focused global manufacturer and seller of prescription, OTC, generic and cosmetic products. It adds significant value to clients production needs through quality, reliability and competitive pricing.
Legacy's manufacturing sites have operated continuously in Europe since 1947 and in the United States since 1975.
Legacy's main areas of business include contract manufacturing and the manufacture and sale of generic, branded generic, niche and specialty pharmaceuticals.
Legacy manufactures and distributes finished pharmaceutical products for over 70 markets worldwide through two business units.
Legacy Pharmaceuticals Puerto Rico is FDA-approved and primarily serves the U.S. and Canada.
Legacy Pharmaceuticals Switzerland is approved by Swissmedic and EMEA. It primarily serves European, Middle Eastern, CIS, and Asia-Pacific markets.
Legacy also owns, manufactures and sells Reptilase and Solcoseryl injections for China and Japan, respectively.
Legacy acquired these sites and the management team from Valeant Pharmaceuticals International in 2007.
The company has 400 employees among its operations in Switzerland and Puerto Rico and its administrative management office in California.
| 
